Riedisheim, France

Gerard Moine

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hoffmann-La Roche Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerard Moine. Retrieved from https://idiyas.com/inventor/gerard-moine-pdovq6wm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Gerard Moine: Innovating Pharmaceutical Preparations

Introduction

Gerard Moine, a notable inventor based in Riedisheim, France, has contributed to the field of pharmaceuticals with his innovative processes. With one patent to his name, he continues to make strides in developing pharmaceutical compounds that hold significant potential for therapeutic applications.

Latest Patents

Gerard Moine's recent patent focuses on a process for the preparation of 7-(4,7-diazaspiro[2.5]octan-7-yl)-2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one derivatives. This invention is particularly noteworthy as it relates to compounds that are pharmaceutically active, highlighting the importance of his work in the medical and pharmaceutical industries.

Career Highlights

Gerard is associated with Hoffmann-La Roche Inc., a company renowned for its dedication to research and development in the pharmaceutical sector. His role there has allowed him to apply his expertise in innovative processes that aid in the creation of new medications.

Collaborations

Throughout his career, Gerard Moine has collaborated with esteemed colleagues, including Jean-Michel Adam and Serena Maria Fantasia. These partnerships reflect the collaborative nature of research in the pharmaceutical industry, where diverse expertise drives innovation.

Conclusion

Gerard Moine exemplifies the spirit of innovation in the pharmaceutical field. His patent signifies a step forward in the development of novel drugs that can potentially enhance medical treatment options. As he continues his work, the impact of his inventions will be closely watched within the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…